Ampelopsin suppresses TNF-α-induced migration and invasion of U2OS osteosarcoma cells

Liu,Changying; Zhao,Pengfei; Yang,Yubao; Xu,Xiaodong; Wang,Liang; Li,Bo

doi:10.3892/mmr.2016.5124

Ampelopsin suppresses TNF-α-induced migration and invasion of U2OS osteosarcoma cells

Authors:
- Changying Liu
- Pengfei Zhao
- Yubao Yang
- Xiaodong Xu
- Liang Wang
- Bo Li
View Affiliations

Affiliations: Department of Osteology, People's Hospital of Linyi City, Linyi, Shandong 276000, P.R. China, Department of Osteology, People's Hospital of Yinan County, Linyi, Shandong 276003, P.R. China, Department of Cardiology, Central Hospital of Zibo, Zibo, Shandong 255036, P.R. China
Published online on: April 13, 2016 https://doi.org/10.3892/mmr.2016.5124
Pages: 4729-4736

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ampelopsin has been suggested as a novel anticancer agent, however, there is no evidence regarding its direct effect on the migration and invasion of osteosarcoma cells. The aims of the present study were to investigate the influence of ampelopsin on the migration and invasion of osteosarcoma cells and to clarify the underlying mechanisms. Scratch wound healing and Transwell assays were used to measure the migratory and invasive activities of the cells, respectively. The protein and RNA levels of matrix metalloproteinase-2 (MMP-2) were detected with western blot and RT-qPCR, respectively, following stimulation with tumor necrosis factor‑α (TNF-α) and ampelopsin. The expression levels of phospho‑ and total-p38MAPK were detected using western blot analysis. Additionally, SB203580, an inhibitor of p38MAPK, was used to investigate the effect of TNF‑α and ampelopsin. The results demonstrated that TNF‑α upregulated the expression level of MMP‑2 and promoted the migration and invasion of osteosarcoma cells. TNF‑α also activated the p38MAPK pathway, and SB203580 significantly inhibited the effect of TNF‑α on MMP‑2 expression. The application of ampelopsin abolished the effects of TNF‑α on the activation of the p38MAPK pathway and the expression of MMP‑2, and downregulated the migration and invasion of the osteosarcoma cells. These results demonstrated that ampelopsin inhibits the TNF‑α‑induced migration and invasion of osteosarcoma cells, and that the effect of ampelopsin was mediated by p38MAPK/MMP‑2 signaling.

View Figures

View References

1	Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
2	Wu PK, Chen WM, Chen CF, Lee OK, Haung CK and Chen TH: Primary osteogenic sarcoma with pulmonary metastasis: Clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol. 39:514–522. 2009. View Article : Google Scholar : PubMed/NCBI
3	Han YP, Tuan TL, Wu H, Hughes M and Garner WL: TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 114:131–139. 2001.
4	Séguin CA, Pilliar RM, Madri JA and Kandel RA: TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration. Spine. 33:356–365. 2008. View Article : Google Scholar : PubMed/NCBI
5	Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L and Yin Z: Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol. 12:278–287. 2012. View Article : Google Scholar
6	Zhou WM, He RR, Ye JT, Zhang N and Liu DY: Synthesis and biological evaluation of new 5-fluorouracil-substituted ampelopsin derivatives. Molecules. 15:2114–2123. 2010. View Article : Google Scholar : PubMed/NCBI
7	Murakami T, Miyakoshi M, Araho D, Mizutani K, Kambara T, Ikeda T, Chou WH, Inukai M, Takenaka A and Igarashi K: Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors. 21:175–178. 2004. View Article : Google Scholar
8	Sayama K, Lin S, Zheng G and Oguni I: Effects of green tea on growth, food utilization and lipid metabolism in mice. In Vivo. 14:481–484. 2000.PubMed/NCBI
9	Ni F, Gong Y, Li L, Abdolmaleky HM and Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of prostate cancer in vitro and in mice. PLoS One. 7:388022012. View Article : Google Scholar
10	Liu T, Liu P, Ding F, Yu N, Li S, Wang S, Zhang X, Sun X, Chen Y, Wang F, et al: Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition. Oncol Rep. 33:861–867. 2015.
11	Zhou Y, Liang X, Chang H, Shu F, Wu Y, Zhang T, Fu Y, Zhang Q, Zhu JD and Mi M: Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress. Cancer Sci. 105:1279–1287. 2014. View Article : Google Scholar : PubMed/NCBI
12	Tsai TT, Ho NY, Lin YT, Lai PL, Fu TS, Niu CC, Chen LH, Chen WJ and Pang JH: Advanced glycation end products in degenerative nucleus pulposus with diabetes. J Orthop Res. 32:238–244. 2014. View Article : Google Scholar
13	Ren P, Sun D, Xin D, Ma W, Chen P, Gao H, Zhang S and Gong M: Serum amyloid A promotes osteosarcoma invasion via upregulating αvβ3 integrin. Mol Med Rep. 10:3106–3112. 2014.PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O and Maelandsmo GM: Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res. 127:151–156. 2005. View Article : Google Scholar : PubMed/NCBI
16	Cheng YC, Kuo WW, Wu HC, Lai TY, Wu CH, Hwang JM, Wang WH, Tsai FJ, Yang JJ, Huang CY and Chu CH: ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells. Mol Cell Biochem. 325:69–77. 2009. View Article : Google Scholar : PubMed/NCBI
17	Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL and Roth M: ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: A comparison between mesothelioma and mesothelial cells. J Cell Physiol. 207:540–552. 2006. View Article : Google Scholar : PubMed/NCBI
18	Schram K, De Girolamo S, Madani S, Munoz D, Thong F and Sweeney G: Leptin regulates MMP-2, TIMP-1 and collagen synthesis via p38 MAPK in HL-1 murine cardiomyocytes. Cell Mol Biol Lett. 15:551–563. 2010. View Article : Google Scholar : PubMed/NCBI
19	Pan F, Ma S, Cao W, Liu H, Chen F, Chen X and Shi R: SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines. Mol Biol Rep. 40:4139–4146. 2013. View Article : Google Scholar : PubMed/NCBI
20	Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL and Reid MB: TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19:362–370. 2005. View Article : Google Scholar : PubMed/NCBI
21	Stjernberg-Salmela S, Ranki A, Karenko L, Siitonen S, Mustonen H, Puolakkainen P, Sarna S, Pettersson T and Repo H: Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford). 49:382–390. 2010. View Article : Google Scholar
22	Bibikova E, Youn MY, Danilova N, Ono-Uruga Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S and Sakamoto KM: TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors. Blood. 124:3791–3798. 2014. View Article : Google Scholar : PubMed/NCBI
23	Wajant H: The role of TNF in cancer. Results Probl Cell Differ. 49:1–15. 2009. View Article : Google Scholar : PubMed/NCBI
24	Wang X and Lin Y: Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 29:1275–1288. 2008. View Article : Google Scholar : PubMed/NCBI
25	Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ and King PH: Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: A role for RNA stabilization and HuR. Cancer Res. 63:4181–4187. 2003.PubMed/NCBI
26	Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A and Balkwill F: The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 67:585–592. 2007. View Article : Google Scholar : PubMed/NCBI
27	Ferrajoli A, Keating MJ, Manshouri T, Giles FJ, Dey A, Estrov Z, Koller CA, Kurzrock R, Thomas DA, Faderl S, et al: The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood. 100:1215–1219. 2002.PubMed/NCBI
28	Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F and Balkwill FR: Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther. 5:382–390. 2006. View Article : Google Scholar : PubMed/NCBI
29	Michalaki V, Syrigos K, Charles P and Waxman J: Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 90:2312–2316. 2004.PubMed/NCBI
30	Tomita Y, Yang X, Ishida Y, Nemoto-Sasaki Y, Kondo T, Oda M, Watanabe G, Chaldakov GN, Fujii C and Mukaida N: Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55. Int J Cancer. 112:927–933. 2004. View Article : Google Scholar : PubMed/NCBI
31	Bates RC and Mercurio AM: Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell. 14:1790–1800. 2003. View Article : Google Scholar : PubMed/NCBI
32	Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR and Binder C: Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis. 25:1543–1549. 2004. View Article : Google Scholar : PubMed/NCBI
33	Villeneuve J, Tremblay P and Vallières L: Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation. Cancer Res. 65:3928–3936. 2005. View Article : Google Scholar : PubMed/NCBI
34	Niforou KM, Anagnostopoulos AK, Vougas K, Kittas C, Gorgoulis VG and Tsangaris GT: The proteome profile of the human osteosarcoma U2OS cell line. Cancer Genomics Proteomics. 5:63–78. 2008.PubMed/NCBI
35	Mori T, Sato Y, Miyamoto K, Kobayashi T, Shimizu T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Tando T, et al: TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state. Oncogene. 33:4236–4341. 2014. View Article : Google Scholar
36	Cooney R, Iocono J, Maish G, Smith JS and Ehrlich P: Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J Trauma. 42:415–420. 1997. View Article : Google Scholar : PubMed/NCBI
37	Kitzis V, Engrav LH and Quinn LS: Transient exposure to tumor necrosis factor-alpha inhibits collagen accumulation by cultured hypertrophic scar fibroblasts. J Surg Res. 87:134–141. 1999. View Article : Google Scholar : PubMed/NCBI
38	Yang YN, Wang F, Zhou W, Wu ZQ and Xing YQ: TNF-α stimulates MMP-2 and MMP-9 activities in human corneal epithelial cells via the activation of FAK/ERK signaling. Ophthalmic Res. 48:165–170. 2012. View Article : Google Scholar
39	Chang H, Peng X, Bai Q, Zhou Y, Yu X, Zhang Q, Zhu J and Mi M: Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway. Carcinogenesis. 35:1847–1854. 2014. View Article : Google Scholar : PubMed/NCBI
40	Luo GQ, Zeng S and Liu DY: Inhibitory effects of ampelopsin on angiogenesis. Zhong Yao Cai. 29:146–150. 2006.In Chinese. PubMed/NCBI